Postoperative Outcomes in Patients With Hepato-biliary-pancreatic Cancer According to inBody Test

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05257434

Enrollment

1000

Registered

2022-02-25

Start date

2019-01-01

Completion date

2030-01-31

Last updated

2022-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

postoperative outcomes were evaluated by using inBody test

Detailed description

postoperative outcomes were evaluated by using inBody test

Interventions

BEHAVIORALinbody

Body fluid composition

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Inclusion criteria

* surgically treated patients

Exclusion criteria

* a body weight loss of \>10% during the 6 months before surgery; the presence of distant metastases; or seriously impaired function of vital organs because of respiratory, renal, or heart disease

Design outcomes

Primary

Measure	Time frame	Description
long-term outcomes	5year	overall survival rate

Secondary

Measure	Time frame	Description
short-term outcomes	up to 24 weeks	postoperative complications

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026